SWING IDEA - JUBILANT PHARMOVAJubilant Pharmova , a diversified global pharmaceutical and life sciences company, offers an attractive swing trade setup with the following technical factors.
Reasons are listed below :
Break of 1000 Resistance : The price has decisively broken above the significant 1000 level and is sustaining, indicating strength and bullish momentum.
Consolidation Breakout : The stock is breaking out of a consolidation phase lasting over 6 years, suggesting a potential long-term uptrend.
Volume Spike : Increased trading volumes highlight growing investor interest and support the breakout.
Engulfing Candle : A bullish engulfing candle on the weekly timeframe reflects strong buying sentiment.
Target - 1450 // 1590
Stoploss - weekly close below 1030
DISCLAIMER -
Decisions to buy, sell, hold or trade in securities, commodities and other investments involve risk and are best made based on the advice of qualified financial professionals. Any trading in securities or other investments involves a risk of substantial losses. The practice of "Day Trading" involves particularly high risks and can cause you to lose substantial sums of money. Before undertaking any trading program, you should consult a qualified financial professional. Please consider carefully whether such trading is suitable for you in light of your financial condition and ability to bear financial risks. Under no circumstances shall we be liable for any loss or damage you or anyone else incurs as a result of any trading or investment activity that you or anyone else engages in based on any information or material you receive through TradingView or our services.
@visionary.growth.insights
Jubilantpharmova
Jubilant Pharmova Ltd : Looking for buyExpecting a potential upside of about 70%.
They supply products and services to customers in over 85 countries. They have four manufacturing facilities in North America and two in India, coupled with Research and Development centres in North America and India. Additionally, they have a distribution network of more than 45 radiopharmacy in the United States.
Leadership Positions
Radiopharmaceuticals
Third largest radiopharmaceutical manufacturer in the nuclear medicine industry in the United States based on revenue
Second largest centralized commercial radiopharmacy network in the United States with a national footprint of more than 45 radiopharmacies across 22 states
Allergy Therapy Products
One of the top three players with a market share of 25% in the allergenic extract market in the United States and are currently the sole producer and supplier of venom products for the treatment of allergies in the United States
APIs
Among the leading global suppliers for several Key APIs.
Solid Dosage Formulations
One of the market leaders in the United States, based on the market share of several key products.